Eye haemorrhage adverse event reports that record this term

Kind of term: MedDRA preferred term

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on 2 Oct 2026. The data have the reports that FDA received through 30 Jun 2026.

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.
Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on 2 Oct 2026.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports on file

From January 2004 to June 2026, FDA received 13,148 adverse event reports that record the MedDRA preferred term Eye haemorrhage. The person who codes a report selects the term that agrees best with the description of the reporter.

FDA received 575 reports in the 12 months to June 2026 and 583 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

The number of people who use the product is not in the data. A count is not a rate.

MedDRA

The Medical Dictionary for Regulatory Activities. The person who codes a report selects the preferred term that agrees best with the description of the reporter. FDA does not publish the description.

Data version

openFDA FAERS release of 1 Oct 2026. Reports received through 30 Jun 2026.

Drugs in these reports

The table has the 121 drug pages with 25 or more reports that record this term. The rows are in order of name. A drug page with fewer reports for this term is not in the table. The counts are the counts that the site keeps for each reaction term, and a count can be lower than the count of FDA.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Drugs that the reports with the term Eye haemorrhage name as a suspect product, in order of name
Drug	Class	Reports with this term
Abatacept	Selective T cell costimulation modulator	31
Acetylsalicylic Acid		56
Actemra	Interleukin-6 receptor antagonist	131
Adcirca	Phosphodiesterase 5 inhibitor	41
Advair Hfa	Corticosteroid	116
Ambrisentan	Endothelin receptor antagonist	60
Apixaban	Factor Xa inhibitor	44
Arava	Antirheumatic agent	69
Aspirin	Nonsteroidal anti-inflammatory drug	205
Avandia		31
Avastin	Vascular endothelial growth factor inhibitor	231
Avonex	Interferon beta	35
Ayvakit	Kinase inhibitor	26
Beovu		79
Bevacizumab	Vascular endothelial growth factor inhibitor	115
Brilinta	P2Y12 platelet inhibitor	48
Byetta	GLP-1 receptor agonist	32
Celebrex	Nonsteroidal anti-inflammatory drug	28
Cialis	Phosphodiesterase 5 inhibitor	37
Ciprofloxacin	Fluoroquinolone antibacterial	25
Clopidogrel	P2Y12 platelet inhibitor	66
Cosentyx	Interleukin-17A antagonist	42
Coumadin		94
Crestor	HMG-CoA reductase inhibitor	61
Cymbalta	Serotonin and norepinephrine reuptake inhibitor	28
Dexamethasone	Corticosteroid	25
Diclofenac	Nonsteroidal anti-inflammatory drug	37
Diclofenac sodium	Nonsteroidal anti-inflammatory drug	29
Diovan	Angiotensin 2 receptor blocker	33
Dupixent	Interleukin-4 receptor alpha antagonist	174
Eliquis	Factor Xa inhibitor	299
Enbrel	Tumor necrosis factor blocker	238
Entresto	Angiotensin 2 receptor blocker	35
Esomeprazole	Proton pump inhibitor	45
Esomeprazole magnesium	Proton pump inhibitor	68
Esomeprazole sodium	Proton pump inhibitor	54
Eylea	Vascular endothelial growth factor inhibitor	781
Fluticasone propionate	Corticosteroid	39
Fluticasone Propionate Salmeterol Xinafoate		29
Forteo	Parathyroid hormone analog	59
Gilenya	Sphingosine 1-phosphate receptor modulator	86
Gleevec	Kinase inhibitor	117
Glivec		44
Hemlibra		42
Humalog	Insulin analog	562
Humalog Mix 75/25		33
Humalog Mix75/25	Insulin analog	31
Humira		448
Humulin 70/30	Insulin	84
Humulin N	Insulin	187
Humulin R	Insulin	220
Hydroxychloroquine	Antimalarial	38
Ibrance	Kinase inhibitor	40
Imbruvica	Kinase inhibitor	253
Insulin glargine	Insulin analog	103
Insulin human	Insulin	77
Insulin lispro	Insulin analog	39
Isophane Insulin		34
Jakafi	Janus kinase inhibitor	45
Lantus	Insulin analog	335
Lantus Solostar	Insulin analog	107
Levemir	Insulin analog	50
Lipitor	HMG-CoA reductase inhibitor	177
Losartan	Angiotensin 2 receptor blocker	132
Lucentis	Vascular endothelial growth factor inhibitor	911
Lumify		27
Lyrica		94
Metformin	Biguanide	33
Methotrexate	Folate analog metabolic inhibitor	113
Methotrexate sodium	Folate analog metabolic inhibitor	39
Mounjaro	GLP-1 receptor agonist	29
Nexium	Proton pump inhibitor	42
Novolog	Insulin analog	69
Novorapid		25
Omeprazole	Proton pump inhibitor	25
Opsumit	Endothelin receptor antagonist	31
Opticlick		31
Orencia	Selective T cell costimulation modulator	90
Otezla	Phosphodiesterase 4 inhibitor	25
Ozempic	GLP-1 receptor agonist	74
Ozurdex	Corticosteroid	35
Pegasys	Interferon alpha	36
Plaquenil	Antimalarial	40
Plavix	P2Y12 platelet inhibitor	147
Pradaxa	Direct thrombin inhibitor	128
Prednisone	Corticosteroid	58
Prolia	RANK ligand inhibitor	34
Ramipril	Angiotensin converting enzyme inhibitor	28
Ranibizumab	Vascular endothelial growth factor inhibitor	106
Rebif	Interferon beta	52
Remicade	Tumor necrosis factor blocker	114
Repatha	PCSK9 inhibitor	29
Restasis	Calcineurin inhibitor immunosuppressant	63
Revlimid	Thalidomide analog	128
Ribavirin	Nucleoside analog antiviral	44
Rinvoq	Janus kinase inhibitor	47
Rituxan	CD20-directed cytolytic antibody	70
Rituximab	CD20-directed cytolytic antibody	76
Rivaroxaban	Factor Xa inhibitor	32
Rosuvastatin	HMG-CoA reductase inhibitor	34
Rosuvastatin calcium	HMG-CoA reductase inhibitor	104
Salmeterol xinafoate	beta2-Adrenergic agonist	61
Simponi	Tumor necrosis factor blocker	93
Skyrizi	Interleukin-23 antagonist	38
Soliris	Complement inhibitor	31
Solostar		53
Sutent	Kinase inhibitor	29
Tasigna	Kinase inhibitor	33
Tecfidera		38
Tiotropium bromide	Anticholinergic	39
Trulicity	GLP-1 receptor agonist	77
Vabysmo		81
Valsartan	Angiotensin 2 receptor blocker	141
Viagra	Phosphodiesterase 5 inhibitor	58
Vioxx		44
Warfarin	Vitamin K antagonist	67
Warfarin sodium	Vitamin K antagonist	59
Xalatan	Prostaglandin analog	57
Xarelto	Factor Xa inhibitor	356
Xeljanz	Janus kinase inhibitor	47
Xiidra		53

The page of each drug has the count of each reaction term in its reaction lookup.

Drug classes in these reports

The table has the 38 pharmacologic classes with 50 or more reports that record this term. The rows are in order of name.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Pharmacologic classes of the drugs that the reports with the term Eye haemorrhage name, in order of name
Class	Reports with this term
Angiotensin 2 receptor blocker	422
Anticholinergic	64
Antimalarial	101
Antirheumatic agent	73
beta-Adrenergic blocker	103
beta2-Adrenergic agonist	63
Calcineurin inhibitor immunosuppressant	82
CD20-directed cytolytic antibody	169
Complement inhibitor	58
Corticosteroid	367
Direct thrombin inhibitor	130
Endothelin receptor antagonist	106
Factor Xa inhibitor	741
Folate analog metabolic inhibitor	155
GLP-1 receptor agonist	247
HMG-CoA reductase inhibitor	403
Insulin	587
Insulin analog	1,407
Interferon beta	87
Interleukin-4 receptor alpha antagonist	192
Interleukin-6 receptor antagonist	131
Janus kinase inhibitor	139
Kinase inhibitor	663
Nonsteroidal anti-inflammatory drug	400
Opioid agonist	100
P2Y12 platelet inhibitor	305
Parathyroid hormone analog	61
Phosphodiesterase 5 inhibitor	173
Prostacycline vasodilator	70
Prostaglandin analog	118
Proton pump inhibitor	254
Selective T cell costimulation modulator	121
Serotonin reuptake inhibitor	69
Sphingosine 1-phosphate receptor modulator	100
Thalidomide analog	153
Tumor necrosis factor blocker	523
Vascular endothelial growth factor inhibitor	2,175
Vitamin K antagonist	126

A class with many reports in all has many reports for almost every term.

Reports by month

Reports that record Eye haemorrhage, by month, five years to June 2026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Patients in these reports

Age of the patient in the reports that record Eye haemorrhage
Age	Reports	Share
Under 2	18	0.1%
2 to 11	80	0.6%
12 to 17	62	0.5%
18 to 44	810	6.2%
45 to 64	2,815	21.4%
65 to 74	1,895	14.4%
75 and over	1,826	13.9%
Age not given	5,642	42.9%

Sex of the patient in the reports that record Eye haemorrhage
Sex	Reports	Share
Female	7,657	58.2%
Male	4,092	31.1%
Unknown or not given	1,399	10.6%

Age and sex are as the report gives them. 57.2% of these reports give the United States as the country.

Terms near this one

These are the next terms in the A to Z list. The links are for navigation.

Official pages

MedWatch Online Voluntary Reporting FormThe online form of FDA for a voluntary report.
MedWatch: The FDA Safety Information and Adverse Event Reporting ProgramThe page of the FDA program that receives reports about drugs and devices.
FDA Adverse Event Monitoring System (AEMS) Public DashboardThe public dashboard of FDA for adverse event reports on drugs and biologics.

The site checked these addresses on 2 Oct 2026. The links open in a new tab.

Cite this page

Reported Reactions. Eye haemorrhage: adverse event reports that record this term. https://reportedreactions.com/reaction/eye-haemorrhage/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of 1 Oct 2026. Reports received through 30 Jun 2026.

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 1 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Oct 2026. A class is the pharmacologic class (EPC) of the FDA label.

The count has the reports with each spelling of one MedDRA preferred term. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

What does Eye haemorrhage mean in an adverse event report?

It is a MedDRA preferred term. FDA codes the description of a reporter with the MedDRA dictionary. The openFDA files do not have the description itself, and this site does not show it.

Does a drug in the table mean that the drug was responsible for this reaction?

No. FDA says:

No individual drug is connected to any individual reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

What does this page tell a person who has this symptom?

This page gives counts of reports. It cannot assess a person. A pharmacist or a clinician can assess a person.

If this is a medical emergency, please call 911.
Source: FDA, MedWatch Online Voluntary Reporting Form. The site read the page on 2 Oct 2026.

To the top of the page